Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
13F holders, Q1 2023
Institutional positions in Jasper Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +23 vs. Q4 2022
- Shares held
- 93.6M
- +79.0M (+540.4%) vs. Q4 2022
- Total value
- $168.8M
- +$162.0M (+2,364.7%) vs. Q4 2022
- New holders
- 28
- 14 more added
- Sold out
- 5
- 2 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $5.05M |
| Q1 2026 | 58 | $13.9M |
| Q4 2025 | 55 | $35.2M |
| Q3 2025 | 60 | $47.8M |
| Q2 2025 | 65 | $69.5M |
| Q1 2025 | 69 | $56.1M |
| Q4 2024 | 88 | $334.5M |
| Q3 2024 | 81 | $274.8M |
| Q2 2024 | 69 | $329.8M |
| Q1 2024 | 61 | $380.2M |
| Q4 2023 | 42 | $61.2M |
| Q3 2023 | 41 | $63.7M |
| Q2 2023 | 46 | $120.0M |
| Q1 2023 | 45 | $168.8M |
| Q4 2022 | 23 | $9.57M |
| Q3 2022 | 23 | $15.7M |
| Q2 2022 | 23 | $37.5M |
| Q1 2022 | 24 | $69.6M |
| Q4 2021 | 25 | $160.7M |
| Q3 2021 | 9 | $101.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Velan Capital Investment Management LP | 11,219,036 | $19.6M | 17.39% | +8,000,000+248.5% | Added |
| BVF Inc | 9,900,000 | $17.9M | 0.66% | +9,900,000 | New |
| Carlyle Group Inc. | 8,761,891 | $15.8M | 0.47% | +8,761,891 | New |
| Qiming U.S. Ventures Management, LLC | 8,519,648 | $15.4M | 18.66% | +2,666,666+45.6% | Added |
| Soleus Capital Management, L.P. | 7,454,980 | $13.5M | 1.67% | +7,454,980 | New |
| Octagon Capital Advisors LP | 6,382,500 | $11.6M | 1.67% | +6,382,500 | New |
| Franklin Resources Inc | 4,500,217 | $8.15M | 0.00% | +4,500,217 | New |
| Sphera Funds Management Ltd. | 4,044,008 | $7.32M | 1.58% | +4,044,008 | New |
| Citadel Advisors LLC | 4,013,038 | $7.26M | 0.01% | +877,998+28.0% | Added |
| Driehaus Capital Management LLC | 4,000,000 | $7.24M | 0.10% | +4,000,000 | New |
| Vanguard Group Inc | 3,726,147 | $6.74M | 0.00% | +3,195,709+602.5% | Added |
| Kingdon Capital Management, L.L.C. | 3,040,000 | $5.50M | 1.29% | +2,500,000+463.0% | Added |
| Woodline Partners LP | 3,000,000 | $5.43M | 0.08% | +3,000,000 | New |
| Ally Bridge Group (NY) LLC | 2,517,232 | $4.56M | 5.97% | +2,517,232 | New |
| RTW Investments, LP | 2,329,809 | $4.22M | 0.09% | +2,329,809 | New |
| Bank of America Corp | 1,781,583 | $3.22M | 0.00% | +1,781,547+4,948,741.7% | Added |
| Nantahala Capital Management, LLC | 1,688,454 | $3.06M | 0.29% | +1,688,454 | New |
| BlackRock Inc. | 1,256,517 | $2.27M | 0.00% | +1,042,394+486.8% | Added |
| Ikarian Capital, LLC | 1,126,287 | $2.04M | 0.85% | +1,126,287 | New |
| Geode Capital Management, LLC | 1,070,314 | $1.94M | 0.00% | +942,898+740.0% | Added |
| Silverarc Capital Management, LLC | 500,000 | $905.0K | 0.41% | +500,000 | New |
| Affinity Asset Advisors, LLC | 476,948 | $863.3K | 0.33% | +476,948 | New |
| Fernwood Investment Management, LLC | 454,706 | $823.0K | 0.32% | 00.0% | Unchanged |
| Morgan Stanley | 378,072 | $684.3K | 0.00% | +375,022+12,295.8% | Added |
| Boothbay Fund Management, LLC | 233,407 | $422.5K | 0.01% | +233,407 | New |
| Jane Street Group, LLC | 211,010 | $381.9K | 0.00% | +211,010 | New |
| State Street Corp | 199,094 | $360.4K | 0.00% | +166,210+505.4% | Added |
| Northern Trust Corp | 155,286 | $281.1K | 0.00% | +133,826+623.6% | Added |
| Squarepoint Ops LLC | 139,887 | $253.2K | 0.00% | +139,887 | New |
| Renaissance Technologies LLC | 110,200 | $199.0K | 0.00% | +44,800+68.5% | Added |
| Man Group plc | – | $135.7K | 0.00% | – | New |
| Citigroup Inc | 64,810 | $117.3K | 0.00% | +64,810 | New |
| Millennium Management LLC | 54,718 | $99.0K | 0.00% | +25,047+84.4% | Added |
| Prelude Capital Management, LLC | 54,500 | $98.6K | 0.01% | +54,500 | New |
| Bank of New York Mellon Corp | 43,593 | $78.9K | 0.00% | +43,593 | New |
| Two Sigma Investments, LP | 42,253 | $76.5K | 0.00% | +42,253 | New |
| Charles Schwab Investment Management Inc | 36,899 | $66.8K | 0.00% | +36,899 | New |
| Jump Financial, LLC | 33,074 | $59.9K | 0.00% | +33,074 | New |
| Goldman Sachs Group Inc | 31,041 | $56.2K | 0.00% | +31,041 | New |
| Forefront Analytics, LLC | 30,290 | $54.8K | 0.03% | −83,710−73.4% | Reduced |
| One68 Global Capital, LLC | 20,000 | $36.2K | 0.05% | +20,000 | New |
| Susquehanna International Group, LLP | 13,822 | $25.0K | 0.00% | −20,544−59.8% | Reduced |
| Wells Fargo & Company | 762 | $1.38K | 0.00% | +492+182.2% | Added |
| Cutler Group LP | 900 | $1.00K | 0.00% | +900 | New |
| Steward Partners Investment Advisory, LLC | 350 | $634 | 0.00% | +350 | New |
| UBS Group AG | 0 | $0 | 0.00% | −215,521−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,494−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −12,839−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |